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SYNTHETIC STUDIES TOWARD HENNOXAZOLE A. USE OF A
SELECTIVE BISOXAZOLE ALKYLATION AS THE KEY FRAGMENT
COUPLING
Thomas E. Smith* and Emily P. Balskus
Department of Chemistry, Williams College, 47 Lab Campus Drive,
Williamstown, MA  01267, USA.  tsmith@williams.edu
Abstract – A model system for side chain fragment coupling to the core of
hennoxazole A is investigated. Lateral metallation of a C13-TBS-protected
bisoxazole, using lithium diethylamide, allows for selective and efficient
alkylation at C15.
INTRODUCTION
Marine natural products containing the oxazole nucleus have drawn considerable attention recently
(Figure 1). Synthetic studies of complex molecules containing isolated 2,4-disubstituted oxazole units
such as the phorboxazoles,1 bisoxazoles such as the hennoxazoles2 and diazonamides,3 and trisoxazoles
such as the ulapualides,4 have contributed methods for the assembly of these systems and have resulted in
several total syntheses. The development of relatively mild oxazole-forming reaction sequences5 has
Figure 1.  Oxazole-Containing Marine Natural Products
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made the late-stage creation of these ring systems a common strategy—with cleavage of an oxazole ring
frequently serving as the key disconnection back to major coupling fragments.6 Approaches involving end
game functionalization of intact oxazole rings, however, provide the opportunity to use relatively simple
oxazoles as starting materials and then efficiently carry these, practically inert,7 heterocycles through a
variety of synthetic transformations.8 In consideration of these issues, our synthesis plan for hennoxazole
A (1, Scheme 1) involves late-stage construction of the C15–C16 bond by metallation of a relatively
elaborate bisoxazole (2) at the C15-methyl position, followed alkylation with an allylic halide C16–C25 side
chain fragment (3).9
Scheme 1.  Retrosynthetic Analysis for Hennoxazole A
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Synthetically useful lateral metallations of some 2-methyl-oxazole and -thiazole systems have been
reported.10 If these rings are unsubstituted at C5, however, competitive deprotonation of the C5-ring
hydrogen is frequently observed (Scheme 2).11 In fact, Williams has shown that bisoxazole 4 is lithiated
with n-BuLi exclusively at the C5'-ring position,
12 suggesting that alkylation of 2 at C15 may be
problematic if R = H. Despite this result, previous work confronting a similar problem in the synthesis of
phorboxazole, demonstrated that the regioselectivity of some oxazole deprotonations can be altered by the
use of lithium diethylamide.13 As elaborated in the preceding communication,14 deprotonation of
Scheme 2.  Oxazole and Bisoxazole Alkylations
BuLi, THF
–78 °C → –40 °C
then  E+
–78 °C → rt O
O
N
N
Me
MeO
E
O
O
N
N
Me
MeO
45
2'
5'
55
2'
5'
4' 4'
O
N
Me
Ph
O
N Ph
Me
O
N Ph
Li
MeI
R2NH
O
N
Me
Ph
Li
MeI
O
N
Me
Ph
Me
+
i. base, –78 °C
ii. MeI, –78 °C
6 7
5
4
2
5
4
2
9
5
4
2
10
5
4
2base
8
5
4
2
n-BuLi
14:86
LiNiPr2
37:63
LiNEt2
99:1
base (7:8)
2-methyl-4-phenyloxazole (6) using n-BuLi at –78 °C followed by alkylation with methyl iodide gives a
14:86 ratio of products (7:8) favoring ring methylation, while the use of LiNEt2 leads to alkylation solely
at the C2-methyl site. This reversal of regioselectivity is thought to arise from the ability of diethylamine
to mediate the low-temperature equilibration of a kinetic mixture of otherwise noninterconverting
lithiated intermediates (9 and 10).15
Herein we report our results  on a model fragment coupling for hennoxazole A using lithium
diethylamide.
RESULTS AND DISCUSSION
To test the viability of our key side chain coupling strategy, we first prepared bisoxazole (13) as a model
substrate (Scheme 3). Bisoxazole ester (11)16 was reduced with DIBAL-H in CH2Cl2 at low temperature
to give aldehyde (12)17 in quantitative yield. Dimethyl acetal (13) was then generated under Noyori
conditions18 in 93% yield. In results consistent with Williams’ studies of 4,12 treatment of bisoxazole (13)
with n-BuLi led to deprotonation exclusively at the C13 ring position (hennoxazole numbering), with no
deprotonation occurring at the C15-methyl group. For this substrate, replacing the base with LDA or
LiNEt2 did not alter the regioselectivity, suggesting that deprotonation at C13 is both kinetically and
thermodynamically favored.19 Attempts to alkylate the dianion of 13 were not fruitful. To circumvent this
dilemma, we chose to block C13 with a silyl protecting group.
20 Although TMS and TES groups were
found to be too labile under these metallation conditions, the TBS group proved to be suitable. Treatment
of 13 with n-BuLi followed by addition of TBSOTf led to C13-protected bisoxazole (15) in 96% yield.
Scheme 3.  Preparation of a Hennoxazole Model System
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To model our key coupling step, we treated protected bisoxazole (15) with several different strong bases
and quenched with MeI (Scheme 4). Gratifyingly, alkylation occurred at the desired C15 site, with LiNEt2
providing the best results. It is interesting to note that n-BuLi and LDA both gave poor conversion and
small amounts of product 17—methylated at both at the C15-methyl and C10-ring positions—at the
expense of starting material conversion.21 No significant monomethylation at C10 was observed. We
speculate that this result could potentially arise from rate differences of the C10- and C15-anions with
respect to alkylation and intermolecular proton exchange. Chelation of lithium between C10 and an
oxygen atom of the C8-dimethyl acetal could decrease the reactivity at this center and lead to the observed
product mixtures. To better mimic the reactivity of the actual side chain fragment (3), we also alkylated
15 with allyl iodide and prenyl bromide, both of which gave excellent results with LiNEt2.
22 Finally,
treatment of alkylated products (18) and (19) with TBAF demonstrated that the oxazole could be cleanly
deprotected under mild conditions.23
Scheme 4.  Hennoxazole Side Chain Alkylation Model Studies
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CONCLUSION
Selective alkylation of a C8–C15 model for the bisoxazole portion of hennoxazole A is possible using
lithium diethylamide when the C13-position is blocked. Thus, modification of our initial retrosynthetic
analysis (Scheme 1) to include a silyl protecting group at C13 (R = TBS) should provide a successful
fragment coupling approach to hennoxazole A. Further reports on this synthesis will be forthcoming.
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